Seer has actively engaged in a share repurchase program, buying back approximately $22 million of Class A common shares. This move has reduced the net total shares outstanding by about 14%, reflecting ...

Management reiterated 2025 revenue guidance of $17 million to $18 million, which represents 24% growth at the midpoint over 2024. Horn stated, "Our guidance range assumes our customers will continue ...

Good day, and welcome to the Seer Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Kelly ...

Revenue: $4.2 million for Q1 2025, a 37% increase from $3.1 million in Q1 2024. Product Revenue: $2.9 million, including $5,000 from related parties. Service Revenue: $1.2 million, including $47,000 ...

Seer, which provides a proteograph product suite for biomedical research, filed on Thursday with the SEC to raise up to $150 million in an initial public offering. The company aims to commercialize ...

If you’re looking at an image of a cell or tissue that’s stained or glowing, there’s a good chance that the signal you’re observing hails from a protein. For years, ligands such as antibodies and ...

At this year’s American Society for Mass Spectrometry (ASMS) conference in Baltimore, Seer unveiled its latest advancement – the new Proteograph® Product Suite featuring the Proteograph ONE Assay and ...